How to Get AndroGel in Nevada

Nevada Telehealth Law and Testosterone Prescribing

Nevada fully authorizes telehealth prescribing of Schedule III controlled substances, including testosterone gel, under NRS 629.515. A provider licensed in Nevada (or holding a Nevada telemedicine license) can evaluate, diagnose, and prescribe AndroGel without an in-person visit.

The Nevada State Board of Medical Examiners updated its telemedicine regulations in 2023, removing the prior requirement for an initial in-person encounter before controlled substance prescribing. This means a first-time patient can complete a synchronous video visit with a Nevada-licensed clinician and receive a testosterone gel prescription the same day, provided laboratory results confirm hypogonadism. The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with unequivocally low testosterone confirmed on at least two morning samples 1. Nevada telehealth providers follow this same standard.

Platforms like HealthRX operate under these state regulations to connect Nevada residents with board-certified physicians who specialize in hormone optimization. The entire process, from lab order to prescription, can occur remotely.

Laboratory Requirements Before Prescribing

Two fasting morning total testosterone levels below 300 ng/dL form the diagnostic foundation. Labs must be drawn between 7:00 AM and 10:00 AM when testosterone peaks in its circadian rhythm.

Beyond total testosterone, Nevada prescribers order a baseline panel that typically includes:

• Free testosterone (calculated or equilibrium dialysis)
• Luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
• Complete blood count with hematocrit
• Prostate-specific antigen (PSA) for men over 40
• Comprehensive metabolic panel
• Lipid panel
• Estradiol (sensitive assay)

The Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled trials enrolling 790 men aged 65 and older with testosterone below 275 ng/dL, demonstrated that testosterone gel improved sexual function, physical function, and vitality scores over 12 months 2. These trials also reinforced that baseline labs and periodic monitoring are non-negotiable for safe therapy.

Quest Diagnostics and Labcorp both operate multiple draw sites across Nevada. Las Vegas alone has over 30 locations. Reno, Henderson, and Sparks each have several. A telehealth provider can send a lab order electronically, and most patients complete their draw within 48 hours of scheduling.

Who Can Prescribe AndroGel in Nevada

Nevada law permits MDs, DOs, NPs, and PAs to prescribe Schedule III controlled substances. Each has slightly different scope-of-practice rules that affect testosterone prescribing.

Physicians (MDs and DOs) hold independent prescriptive authority for all schedules. Nurse practitioners in Nevada gained full practice authority under AB 170 (2013) after completing a supervised transition period. An NP with a DEA registration and Nevada PDMP enrollment can independently prescribe testosterone gel without physician oversight. Physician assistants prescribe under a collaborative agreement with a supervising physician, but the supervising physician does not need to co-sign each testosterone prescription individually.

Dr. James Hotaling, a urologist and men's health researcher at the University of Utah (who treats Nevada patients via telehealth), has noted: "The biggest barrier to TRT access in the Mountain West is not regulatory. It is awareness. Many men with classic hypogonadal symptoms never get a testosterone level checked because they attribute fatigue and low libido to aging."

All prescribers must verify the patient's identity, check the Nevada Prescription Drug Monitoring Program (PDMP) database before issuing a Schedule III prescription, and document clinical necessity in the medical record.

Insurance Coverage and Prior Authorization

Nevada Medicaid does not cover brand-name AndroGel. Generic testosterone gel 1% (authorized generics by Perrigo and Teva) may receive coverage under certain managed Medicaid plans with prior authorization.

Commercial insurers in Nevada, including UnitedHealthcare, Anthem Blue Cross Blue Shield, Cigna, and Aetna, generally cover generic testosterone gel 1% on Tier 2 or Tier 3 formulary placement. Brand-name AndroGel 1.62% typically sits on Tier 4 (specialty) or requires a formulary exception.

Prior authorization documentation for Nevada commercial plans usually requires:

• Two laboratory-confirmed testosterone values below 300 ng/dL
• Documentation of signs and symptoms (fatigue, decreased libido, erectile dysfunction, loss of muscle mass)
• Notation that secondary causes were ruled out (pituitary MRI if LH/FSH low, thyroid function, prolactin)
• Trial-and-failure documentation if the plan mandates step therapy (e.g., injectable testosterone cypionate first)

The American Urological Association's 2018 guideline defines testosterone deficiency as a total testosterone below 300 ng/dL combined with symptoms, which aligns with most Nevada payer policies 3.

Turnaround on prior authorization in Nevada averages 3 to 5 business days for electronic submissions. Some telehealth platforms handle the PA process on behalf of the patient, reducing administrative burden.

503A Compounding Pharmacies in Nevada

Nevada licenses 503A compounding pharmacies through the Nevada State Board of Pharmacy. These pharmacies can compound testosterone gel in custom concentrations (commonly 5%, 10%, or 20% formulations) for individual patients with valid prescriptions.

A 503A pharmacy compounds medications based on a patient-specific prescription. This differs from 503B outsourcing facilities, which produce larger batches without individual prescriptions. Nevada's 503A pharmacies can ship compounded testosterone gel directly to patients within the state.

Compounded testosterone gel costs between $30 and $90 per month in Nevada, depending on concentration, base vehicle, and quantity. This represents significant savings over brand-name AndroGel 1%, which carries a cash price exceeding $600 per month without insurance.

The FDA's guidance on compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act requires that the pharmacy compound from bulk pharmaceutical-grade ingredients, maintain proper potency testing, and dispense only upon receipt of a valid prescription 4. Nevada compounders must also meet United States Pharmacopeia (USP) Chapter 795 standards for non-sterile compounding.

Several Nevada-based compounding pharmacies operate in Las Vegas, Reno, and Henderson. Out-of-state 503A pharmacies cannot legally ship compounded testosterone into Nevada unless they hold a Nevada non-resident pharmacy license.

Timeline From Consult to Medication in Hand

Most Nevada patients receive their testosterone gel within 5 to 10 days of initiating the process. Here is the typical sequence:

Day 1: Schedule telehealth consultation and receive electronic lab order. Day 2 to 3: Complete morning blood draw at a Nevada lab location. Day 4 to 5: Lab results return; provider reviews and schedules synchronous video visit. Day 5 to 6: Video consultation, diagnosis confirmed, prescription transmitted electronically. Day 7 to 10: Pharmacy fills prescription; patient picks up or receives shipment.

If prior authorization is required, add 3 to 5 business days. Compounding pharmacies may add 2 to 3 days for preparation compared to dispensing a manufactured product off the shelf.

Rush processing is possible. Some telehealth platforms offer same-day lab review and prescribing if bloodwork arrives before a certain cutoff. Patients in Las Vegas and Reno, with their higher density of lab draw sites and pharmacies, generally experience faster turnaround than those in rural Nevada counties.

Transferring an Existing Prescription to Nevada

Nevada accepts prescription transfers for Schedule III through V controlled substances from other states. A patient moving to Nevada or visiting long-term can have their out-of-state pharmacy transfer remaining refills to a Nevada pharmacy.

The receiving Nevada pharmacist contacts the transferring pharmacy, verifies the prescription details, and logs the transfer in the Nevada PDMP. The original prescription is then invalidated at the originating pharmacy. Nevada requires that the prescriber hold an active license in the state where the prescription was originally written.

For ongoing care, patients relocating to Nevada should establish with a Nevada-licensed provider. A telehealth visit specifically for care continuity is straightforward. Bring prior lab results, current dose, and treatment history. Most Nevada providers will continue an existing stable regimen without requiring a new diagnostic workup, provided recent labs (within 6 months) confirm appropriate testosterone levels and normal hematocrit.

Monitoring and Follow-Up Requirements

The Endocrine Society guideline recommends checking testosterone levels 2 to 4 hours after gel application, targeting a mid-normal range of 450 to 600 ng/dL at 3 months, then every 6 to 12 months thereafter 1.

Hematocrit monitoring is the most clinically significant safety parameter. Testosterone therapy can stimulate erythropoiesis, raising hematocrit above 54%, which increases thrombotic risk. The TRAVERSE trial (N=5,204), published in the New England Journal of Medicine in 2023, found that testosterone replacement in men aged 45 to 80 with cardiovascular risk did not increase major adverse cardiovascular events compared to placebo over a mean 33-month follow-up 5. This trial significantly changed the risk-benefit conversation around TRT.

Nevada telehealth providers typically schedule follow-up labs at 6 weeks, 3 months, 6 months, and then annually. Each monitoring visit includes total testosterone, free testosterone, hematocrit, PSA (if applicable), and estradiol. Adjustments to dosing occur based on these results and symptom assessment.

Dose Forms and Application Instructions

AndroGel 1% delivers 50 mg of testosterone per 5-gram packet (or two pump actuations). AndroGel 1.62% delivers 40.5 mg per 1.25-gram pump actuation. The FDA-approved starting dose for AndroGel 1% is 50 mg daily, applied to shoulders, upper arms, or abdomen 6.

Application rules that affect absorption:

• Apply to clean, dry, intact skin
• Do not apply to the genitals or chest
• Allow 5 to 10 minutes of drying time before dressing
• Wash hands thoroughly after application
• Avoid skin-to-skin contact with others at the application site for at least 2 hours
• Shower or swim only after 5+ hours post-application

Dose titration occurs based on serum testosterone levels. If levels remain below 300 ng/dL at the 50 mg dose, providers increase to 75 mg or 100 mg daily. The maximum approved dose of AndroGel 1% is 100 mg daily.

Cost Breakdown for Nevada Patients

Brand-name AndroGel 1% runs $580 to $720 per month at Nevada retail pharmacies without insurance. Generic testosterone gel 1% (Teva, Perrigo) costs $80 to $200 per month cash price, with GoodRx-type coupons sometimes bringing it below $60.

Compounded testosterone gel from Nevada 503A pharmacies typically costs $30 to $90 per month. This option works best for patients without insurance coverage or those whose plans exclude topical testosterone.

With commercial insurance and formulary coverage (after prior authorization), patient copays for generic testosterone gel range from $10 to $75 per month depending on plan tier placement and deductible status.

The total cost of starting TRT in Nevada, including initial labs ($150 to $300 if self-pay), telehealth consultation ($99 to $250), and first month of medication, ranges from $250 to $800 depending on the pathway chosen.